• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包括相邻器官的扩大切除术和Ki-67标记指数是腹膜后软组织肉瘤患者的预后因素。

Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.

作者信息

Morizawa Yosuke, Miyake Makito, Shimada Keiji, Hori Shunta, Tatsumi Yoshihiro, Nakai Yasushi, Anai Satoshi, Tanaka Nobumichi, Konishi Noboru, Fujimoto Kiyohide

机构信息

Department of Urology, Nara Medical University, 840 Shijo-cho, Nara, 634-8522, Japan.

Department of Pathology, Nara Medical University, Nara, Japan.

出版信息

World J Surg Oncol. 2016 Feb 24;14(1):43. doi: 10.1186/s12957-016-0810-z.

DOI:10.1186/s12957-016-0810-z
PMID:26911364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4765233/
Abstract

BACKGROUND

Because retroperitoneal soft tissue sarcomas (RPS) are extremely rare, there is a significant lack of clinicopathologic information to optimize the treatment strategy. The aim of this study was to evaluate the prognostic factors in RPS, with particular focus on the Ki-67 labeling index (LI).

METHODS

We included the data from a total of 23 patients who received treatment for primary RPS at a single center. The variables analyzed in this study included tumor size, histological type, malignancy grade, necrosis, mitosis, and Ki-67 LI. Kaplan-Meier and Cox proportional regression analyses of overall survival (OS) were performed to identify significant prognostic variables.

RESULTS

Of the 23 patients who underwent surgical resection, 9 (39%) underwent simple resection of the tumor and 14 (61%) extended resection including the adjacent organs. In the univariate analysis, a simple tumor resection and a high Ki-67 LI were associated with shorter OS. The multivariate analysis revealed that simple tumor resection and a high Ki-67 LI were independent negative prognostic factors for OS.

CONCLUSIONS

Our results suggested that combined resection of RPS and its adjacent organs improved OS. Pathologically, a high Ki-67 LI was significantly associated with negative prognosis.

摘要

背景

由于腹膜后软组织肉瘤(RPS)极为罕见,严重缺乏优化治疗策略所需的临床病理信息。本研究的目的是评估RPS的预后因素,尤其关注Ki-67标记指数(LI)。

方法

我们纳入了在单一中心接受原发性RPS治疗的23例患者的数据。本研究分析的变量包括肿瘤大小、组织学类型、恶性程度、坏死、有丝分裂和Ki-67 LI。进行Kaplan-Meier和Cox比例回归分析总生存期(OS),以确定显著的预后变量。

结果

在接受手术切除的23例患者中,9例(39%)进行了肿瘤单纯切除,14例(61%)进行了包括相邻器官的扩大切除。单因素分析中,肿瘤单纯切除和高Ki-67 LI与较短的OS相关。多因素分析显示,肿瘤单纯切除和高Ki-67 LI是OS的独立阴性预后因素。

结论

我们的结果表明,RPS及其相邻器官的联合切除可改善OS。病理上,高Ki-67 LI与不良预后显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6851/4765233/80f638d15441/12957_2016_810_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6851/4765233/dd37d03a19b9/12957_2016_810_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6851/4765233/80f638d15441/12957_2016_810_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6851/4765233/dd37d03a19b9/12957_2016_810_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6851/4765233/80f638d15441/12957_2016_810_Fig2_HTML.jpg

相似文献

1
Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.包括相邻器官的扩大切除术和Ki-67标记指数是腹膜后软组织肉瘤患者的预后因素。
World J Surg Oncol. 2016 Feb 24;14(1):43. doi: 10.1186/s12957-016-0810-z.
2
Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304.日本临床肿瘤学组研究JCOG0304中Ki-67系统在软组织肉瘤组织学分级中的前瞻性评估。
World J Surg Oncol. 2016 Apr 18;14:110. doi: 10.1186/s12957-016-0869-6.
3
A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.一项当代针对切除性腹膜后肉瘤的大型单机构评估。
Ann Surg Oncol. 2014 Jul;21(7):2150-8. doi: 10.1245/s10434-014-3616-7. Epub 2014 Mar 11.
4
Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.复发性腹膜后肉瘤:手术治疗的临床结果和预后因素。
Eur J Surg Oncol. 2021 May;47(5):1201-1206. doi: 10.1016/j.ejso.2020.08.030. Epub 2020 Sep 9.
5
Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.腹膜后肉瘤切除术后生存的预测因素:基于人群的分析和 AJCC 分期系统的批判性评估。
Ann Surg. 2009 Dec;250(6):970-6. doi: 10.1097/SLA.0b013e3181b25183.
6
Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.腹膜后软组织肉瘤的预后因素:132例分析
Chin Med J (Engl). 2007 Jun 20;120(12):1047-50.
7
Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.化疗对手术切除的腹膜后肉瘤患者生存的影响。
Eur J Surg Oncol. 2015 Oct;41(10):1386-92. doi: 10.1016/j.ejso.2015.07.014. Epub 2015 Jul 29.
8
The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.显微镜下切缘状态对成人腹膜后软组织肉瘤生存的影响。
Eur J Surg Oncol. 2017 Jan;43(1):168-174. doi: 10.1016/j.ejso.2016.05.031. Epub 2016 Jun 10.
9
Impact of histology on survival in retroperitoneal sarcomas.组织学对腹膜后肉瘤生存的影响。
Am J Surg. 2011 Dec;202(6):748-52; discussion 752-3. doi: 10.1016/j.amjsurg.2011.09.001. Epub 2011 Oct 25.
10
Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.腹膜后软组织肉瘤个体化治疗方法:初次扩大切除术后的组织学特异性复发模式及复发后结局
Ann Surg Oncol. 2015 May;22(5):1447-54. doi: 10.1245/s10434-014-4130-7. Epub 2014 Oct 10.

引用本文的文献

1
Clinical features and surgical strategy of retroperitoneal liposarcoma involving the kidney capsule: a retrospective comparative cohort study.腹膜后脂肪肉瘤累及肾被膜的临床特征和手术策略:一项回顾性对比队列研究。
Int J Surg. 2024 Sep 1;110(9):5355-5362. doi: 10.1097/JS9.0000000000001774.
2
Da Vinci robot-assisted retroperitoneal tumor resection in 105 patients: a single-center experience.105例患者的达芬奇机器人辅助腹膜后肿瘤切除术:单中心经验
Front Oncol. 2024 Jul 23;14:1414780. doi: 10.3389/fonc.2024.1414780. eCollection 2024.
3
Primary well differentiated hepatic liposarcoma in a meerkat (Suricata suricatta).

本文引用的文献

1
Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.完全手术切除后,区域高热与化疗联合治疗高危腹膜后和腹部软组织肉瘤的疗效:一项随机 III 期多中心研究的亚组分析。
Ann Surg. 2014 Nov;260(5):749-54; discussion 754-6. doi: 10.1097/SLA.0000000000000978.
2
Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival.经皮穿刺针芯活检用于腹膜后肉瘤,不影响局部复发或总生存期。
Ann Surg Oncol. 2015 Mar;22(3):853-8. doi: 10.1245/s10434-014-4059-x. Epub 2014 Sep 5.
3
在獴(猫鼬)中发现的原发性高分化肝脂肪肉瘤。
J Vet Med Sci. 2023 Jun 1;85(6):609-612. doi: 10.1292/jvms.22-0572. Epub 2023 Apr 25.
4
Survival outcomes of surgery for retroperitoneal sarcomas: A systematic review and meta-analysis.腹膜后肉瘤手术治疗的生存结局:系统评价和荟萃分析。
PLoS One. 2022 Jul 28;17(7):e0272044. doi: 10.1371/journal.pone.0272044. eCollection 2022.
5
Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.利用生物信息学分析鉴定滑膜肉瘤中与转移相关的生物标志物
Front Genet. 2020 Sep 11;11:530892. doi: 10.3389/fgene.2020.530892. eCollection 2020.
6
Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.腹膜后肉瘤肿瘤细胞中临床病理参数与PD-L1、PD-L2及PD-1表达的综合评估
Oncol Lett. 2020 Nov;20(5):190. doi: 10.3892/ol.2020.12052. Epub 2020 Sep 3.
7
Short-term outcomes after duodenal surgery for mesenchymal tumors: a retrospective analysis from a single tertiary referral center.十二指肠间质瘤手术治疗的近期疗效:单中心回顾性研究。
Updates Surg. 2019 Sep;71(3):451-456. doi: 10.1007/s13304-019-00667-8. Epub 2019 Jul 3.
8
The diagnostic utility of retroperitoneoscopic tissue biopsy for unresectable retroperitoneal lesions excluding urogenital cancers.经腹膜后镜组织活检对除泌尿生殖系统癌症以外的不可切除腹膜后病变的诊断价值。
World J Surg Oncol. 2019 Feb 18;17(1):35. doi: 10.1186/s12957-019-1581-0.
9
Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy.在肿瘤细胞和尿液中检测到的集落刺激因子是接受根治性膀胱切除术的肌层浸润性膀胱癌患者的潜在预后标志物。
Res Rep Urol. 2018 Sep 21;10:103-111. doi: 10.2147/RRU.S166497. eCollection 2018.
Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
腹膜后肉瘤的辅助放疗。斯堪的纳维亚肉瘤研究组对97例患者的研究。
Acta Oncol. 2014 Sep;53(9):1165-72. doi: 10.3109/0284186X.2014.921723. Epub 2014 Jul 7.
4
Radiation therapy for retroperitoneal sarcoma.腹膜后肉瘤的放射治疗。
Radiol Med. 2014 Oct;119(10):790-802. doi: 10.1007/s11547-013-0350-3. Epub 2014 Mar 18.
5
Quality of local treatment or biology of the tumor: which are the trump cards for loco-regional control of retroperitoneal sarcoma?局部治疗质量还是肿瘤生物学特性:哪一项是腹膜后肉瘤局部区域控制的王牌?
Ann Surg Oncol. 2013 Jul;20(7):2111-3. doi: 10.1245/s10434-013-2971-0.
6
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.Jab1、p16、p21、p62、Ki67 和 Skp2 在软组织肉瘤中的预后影响。
PLoS One. 2012;7(10):e47068. doi: 10.1371/journal.pone.0047068. Epub 2012 Oct 5.
7
Improving outcomes for retroperitoneal sarcomas: a work in progress.改善腹膜后肉瘤的治疗效果:一项正在进行的工作。
Surg Oncol Clin N Am. 2012 Apr;21(2):317-31. doi: 10.1016/j.soc.2012.01.002.
8
Retroperitoneal sarcoma: is it time to change the surgical policy?腹膜后肉瘤:是否到了改变手术策略的时候?
Ann Surg Oncol. 2011 Aug;18(8):2136-42. doi: 10.1245/s10434-011-1742-z. Epub 2011 May 3.
9
Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.在一项对腹膜后软组织肉瘤患者进行回顾性研究的单机构病例系列中采用的积极手术策略。
J Clin Oncol. 2009 Jan 1;27(1):24-30. doi: 10.1200/JCO.2008.17.8871. Epub 2008 Dec 1.
10
Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.原发性腹膜后肉瘤:与局部控制相关的手术因素的多变量分析
J Clin Oncol. 2009 Jan 1;27(1):31-7. doi: 10.1200/JCO.2008.18.0802. Epub 2008 Dec 1.